Fintel reports that on January 21, 2025, TD Cowen initiated coverage of Forte Biosciences (NasdaqCM:FBRX) with a Buy ...
TD Cowen analyst Ritu Baral maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) today and set a price target of $9.00. The ...
Celsius Holdings (NASDAQ:CELH) swung lower in early trading on Wednesday after TD Cowen downgraded the energy drink stock to a Hold rating after having it set at Buy. Notably, the firm's retail ...
Exxon Mobil Corp (XOM) stock saw a modest uptick, ending the day at $112.32 which represents a slight increase of $1.00 or 0.90% from the prior close of $111.32. The stock opened at $111.03 and ...
Kimberly-Clark Corp (KMB) stock saw a modest uptick, ending the day at $127.22 which represents a slight increase of $0.57 or 0.45% from the prior close of $126.65. The stock opened at $126.77 and ...
With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...
Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE:COP) with a "Buy" rating and a $125 price target, noting its vast asset base, low-cost operations, and long-term growth drivers ...
Salesforce has been upgraded to a Buy from TD Cowen analysts, who also raised their price target to $400 per share citing the year-end stock rally tied to the deployment of the Agentforce AI product.
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...
Investing.com -- TD Cowen managing director Jaret Seiberg raised concerns that the recent issuance of a Donald Trump meme coin could pose challenges to bipartisan efforts to pass cryptocurrency market ...
TD Cowen upgraded Salesforce's (NYSE:CRM) rating to Buy from Hold and raised the price target to $400 from $380. Shares of Salesforce rose about 2% on Friday. Analysts led by Derrick Wood said ...
We recently published a list of 12 Most Undervalued Stocks to Invest in for Under $20. In this article, we are going to take ...